Skip to main content

John P. Condon

Member

[email protected]

+1.617.348.4453

Share:

John’s practice focuses on corporate and securities law matters, with emphasis on the biotechnology, medical device and technology industries.

John represents issuers preparing for and completing initial public offerings, de-SPAC and reverse merger transactions, follow-on offerings, ATM offerings and PIPEs. John also represents underwriters in capital markets transactions. In addition, John serves as outside corporate and securities counsel to public companies and advises on a broad range of corporate governance and securities compliance matters, including SEC requirements, Nasdaq and NYSE listing rules and proxy advisory firm policies.

John also advises entrepreneurs of early stage companies on formation, capital raising transactions and corporate governance matters, including through his involvement with the Massachusetts Medical Device Development Center (M2D2).

Prior to becoming an attorney, John worked as a legal assistant in the Securities Litigation Practice at Mintz Levin. He also interned at the Boston College Legal Assistance Bureau, the Massachusetts Clients’ Security Board of the Supreme Judicial Court, the Massachusetts Attorney General’s Office, and the U.S. Senate Committee on the Judiciary.

viewpoints

Viewpoint Thumbnail

Preparation for 2023 Fiscal Year-End SEC Filings and 2024 Annual Shareholder Meetings

December 15, 2023 | Advisory | By John Condon, Anne Bruno, Melanie Ruthrauff Levy, Jacob Hupart, Cynthia Larose, Breton Leone-Quick, Page R. Hubben, Ellen Shapiro

Public companies need to consider regulatory, legal, market, and ESG-related developments in preparing for their fiscal year-end filings with the SEC and their annual shareholder meetings. In an in-depth memorandum, Mintz attorneys discuss the SEC’s new cybersecurity disclosure rule, recent trends in reverse stock splits, and the SEC’s disclosure requirements for Rule 10b5-1 trading plans and insider trading policies, and other emerging issues affecting public companies.
Read more
Privacy & Thumbnail Viewpoints Thumbnail

SEC Adopts Final Cybersecurity Rules for Public Companies

August 1, 2023 | Blog | By Cynthia Larose, John Condon, Michael Katz, Stefan Jović

The SEC adopted its final rules and amendments concerning cybersecurity risk management, strategy, governance, and incident disclosure (the “Final Rule”) on July 26, 2023.  In this article we highlight some of the principal changes to the cybersecurity rules first proposed by the SEC more than 16 months prior.
Read more
Securities & Capital Markets Viewpoints Thumbnail

SEC Adopts Final Cybersecurity Rules for Public Companies

August 1, 2023 | Blog | By Cynthia Larose, John Condon, Michael Katz, Stefan Jović

The SEC adopted its final rules and amendments concerning cybersecurity risk management, strategy, governance, and incident disclosure (the “Final Rule”) on July 26, 2023.  In this article we highlight some of the principal changes to the cybersecurity rules first proposed by the SEC more than 16 months prior.
Read more

A Quantitative Analysis of Comment Letters Issued by the SEC Concerning Climate Change Disclosures

June 8, 2023 | Advisory | By Jacob Hupart, Doug Baumstein, Thomas R. Burton, III, John Condon, Will G. McKitterick, Jaidyn M. Jackson, Tucker Kelsch

From July 2021 through March 2023, the SEC sent reporting entities more than 100 letters seeking information on climate change topics and nearly 170 letters concerning greenwashing. In an in-depth analysis, Mintz attorneys identify and analyze the frequency of various categories of questions as well as the industries and characteristics of the businesses targeted.
Read more
Viewpoint Thumbnail

Preparation for 2022 Fiscal Year-End SEC Filings and 2023 Annual Shareholder Meetings

December 7, 2022 | Advisory | By John Condon, Anne Bruno, Melanie Ruthrauff Levy, Jacob Hupart, Cynthia Larose, Breton Leone-Quick, Page R. Hubben

Read more

SEC Proposes New Cybersecurity Rules for Public Companies

March 21, 2022 | Advisory | By Roman M. Gorokhov, Cynthia Larose, Megan Gates, John Condon

Read more

Preparation for 2021 Fiscal Year-End SEC Filings and 2022 Annual Shareholder Meetings

January 18, 2022 | Advisory | By Megan Gates, John Condon, Anne Bruno, Melanie Ruthrauff Levy, Daniel T. Kajunski, Cynthia Larose, Breton Leone-Quick, Page R. Hubben

Read about key regulatory and other developments, including board diversity and other ESG matters, which public companies need to consider as they prepare for their fiscal year-end SEC filings and 2022 annual shareholder meetings.
Read more

Preparation for 2020 Fiscal Year-End SEC Filings and 2021 Annual Shareholder Meetings

January 21, 2021 | Advisory | By Megan Gates, John Condon, Daniel T. Kajunski, Anne Bruno

Read about regulatory and other developments public companies need to consider as they prepare for fiscal year-end Securities and Exchange Commission filings and 2021 annual shareholder meetings.
Read more

Preparation for 2019 Fiscal Year-End SEC Filings and 2020 Annual Shareholder Meetings

January 23, 2020 | Advisory | By Megan Gates, John Condon, Anne Bruno

Read about regulatory developments affecting public companies as they prepare for fiscal year-end Securities and Exchange Commission filings and annual shareholder meetings.
Read more
Public companies will soon be required to include an active hyperlink to each exhibit to all registration statements filed under the Securities Act of 1933, as amended, and all periodic and current reports filed under the Securities Exchange Act of 1934, as amended, filed on or after September 1, 2017.
Read more
Read less

News & Press

News Thumbnail
Members Douglas P. Baumstein and John Condon, and Associates Patrick McDonough and Aaron Megar co-authored an article published in the May 2023 Issue of The Banking Law Journal. The article provides an in depth review of the case Slack Technologies, LLC v. Pirani.
News Thumbnail
Mintz's role acting for biotechnology company Albireo Pharma in its sale to Ipsen was covered in The Deal. The article featured Mintz Members Megan Gates, and John Condon and Associate Garrett Galvin, who led for the firm.
Press Release Thumbnail
Firm plays a key role in the largest health care acquisition to date in 2020.
Mintz represented G1 Therapeutics, Inc. in its initial public offering of 7,781,564 shares of common stock. G1 Therapeutics is a clinical-stage biopharmaceutical company.
Mint has been named an official gold sponsor of the MIT 100K Entrepreneurship Competition. The event is a launch pad for students and researchers in the MIT community to act on their talent, ideas, and energy to produce tomorrow’s leading ventures.
Read less

Events & Speaking

Speaker
Apr
1
2023

Aspiring Public Company Director Program

National Association of Corporate Directors – New England Chapter

Conference Reference Image
Speaker
Jan
24
2023
Webinar Reference Image
Speaker
May
6
2021
Webinar Reference Image
Speaker
Nov
20
2019

Recent SEC Rulemaking

Boston Bar Association

Read less

Involvement

  • Co-Chair, Business Transactions Section of the Boston Bar Association, Past Co-Chair of the Securities Law Committee of the Boston Bar Association
  • Board of Directors, United Methodist Foundation of New England
  • Advisory Board, The Massachusetts Medical Device Development Center (M2D2)
  • Contributor, Securities Matters blog
  • Mentor, including for the M2D2 $200K Challenge and MIT $100K Pitch Contest
  • Member of the Endowment Committee; Past Chair of Church Council, Associate Lay Leader and Member of Pastor Transition Team, Sudbury United Methodist Church
Read less